Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trialSylvie Chevret, Sabrina Brahmi, Claire Dupuis et al.|Annals of Intensive Care|2023Cited by 3